Skip to content

Insider · CIK 0001445710

Patricia S Andrews

director

Files at GERN (GERON CORP), ONCY (ONCOLYTICS BIOTECH INC). First filing Feb 13, 2026, latest Feb 13, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$30k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ONCY: ONCOLYTICS BIOTECH INC

ONCYOct 9, 2026 · close 0.56

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
45Moderate
ONCYbuy 9
ONCOLYTICS BIOTECH INC
$30k
35,400 shares
+83%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 1, 2026ONCY
ONCOLYTICS BIOTECH INC
AGrant or award
Stock Optionderivative
+30,000$0.00$030,000Jun 3, 2026
Mar 25, 2026GERN
GERON CORP
AGrant or award
Stock Option (Right to Buy)derivative
+270,000$0.00$0270,000Mar 26, 2026
Feb 12, 2026ONCY
ONCOLYTICS BIOTECH INC
POpen-market purchase
Common Shares
+35,400$0.86$30k78,128Feb 13, 2026

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Patricia S Andrews: insider trades and track record | InsiderTell